February 2010, Hikma Pharmaceuticals introduces Respirox; the Atypical antipsychotic, to Tunisian market. The active ingredient Risperidone is one of...
February 2010, Hikma Pharmaceuticals introduces Respirox; the Atypical antipsychotic, to Tunisian market. The active ingredient Risperidone is one of...
Study proves 90 % success rate for Factive
Gemifloxacin Evaluation in treating Acute bacterial Rhino-Sinusitis (GEARS study) has been conducted and expected to be published in an international...
Gemifloxacin Evaluation in treating Acute bacterial Rhino-Sinusitis (GEARS study) has been conducted and expected to be published in an international...
Actos
The most recent AACE treatment Guideline put TZD group (the group which actos belongs to) as the first line treatment option for type 2 Diabetic...